# Actilyse 50mg intravenous infusion vial

## Actilyse 50mg powder for intravenous infusion

Actilyse 50mg by Boehringer Ingelheim contains alteplase, a recombinant tissue plasminogen activator (rt-PA). Alteplase promotes the conversion of plasminogen to plasmin, which breaks down fibrin within blood clots. Treatment does not guarantee immediate restoration of blood flow.

### What is Actilyse used for?

Actilyse is used in selected cases of acute ischaemic stroke, acute myocardial infarction and acute pulmonary embolism under specialist hospital protocols. Eligibility, timing and treatment regimens differ by indication. It is not appropriate for every stroke, heart attack or blood clot.

### Product details

-   Brand: Actilyse.
-   Manufacturer: Boehringer Ingelheim.
-   Active ingredient: alteplase.
-   Strength: 50 mg per vial.
-   Form: powder for preparation of an intravenous solution.

### Preparation and administration

Reconstitution, dosing, infusion rate and monitoring must follow the manufacturer's instructions and the indication-specific hospital protocol. A single preparation or infusion regimen must not be assumed to apply to every emergency.

### Important precautions

Alteplase can cause severe or fatal bleeding, including bleeding inside the brain. Active bleeding, suspected intracranial haemorrhage, recent surgery or trauma, uncontrolled blood pressure and clotting disorders require specialist assessment. The full contraindications depend on the treatment indication.

### Possible side effects

Possible adverse effects include bleeding at injection sites, internal bleeding and allergic reactions. Treatment requires close clinical monitoring. Refer to the product information for complete safety details.

### Frequently asked questions

**Is Actilyse the same as Actemra?**  
No. Actilyse contains alteplase. Actemra contains tocilizumab and is a different medicine.

**Can it be combined with other blood-thinning medicines?**  
Anticoagulants and antiplatelet medicines can increase bleeding risk. Any combination and its timing must be managed by the specialist clinical team.

**How long can the prepared solution be kept?**  
The clinical team must follow the manufacturer's validated storage and aseptic preparation instructions for the supplied product.

This product page is not an emergency treatment service. Suspected stroke, heart attack or pulmonary embolism requires immediate emergency care.

## Details

- **Price:** 21997.0 EGP
- **Vendor:** Boehringer Ingelheim
- **Type:** Specialized medications
- **Tags:** Actilyse 50mg, Alteplase, Boehringer Ingelheim, Specialized medications, Thrombolytic

## Variants

| Variant | Price | Available |
|---------|-------|-----------|
| Default Title | 21997.00 EGP | In stock |

## Images

- Actilyse 50mg intravenous infusion vial

---

> Source: [Mai Pharmacy](https://maipharmacy.co/products/actilyse-50mg-intravenous-vial)
> Updated: 2026-10-27